Target Name: MIR6762
NCBI ID: G102465457
Review Report on MIR6762 Target / Biomarker Content of Review Report on MIR6762 Target / Biomarker
MIR6762
Other Name(s): microRNA 6762 | MicroRNA 6762 | hsa-miR-6762-3p | hsa-mir-6762 | hsa-miR-6762-5p

miRNA 6762: A Potential Drug Target and Biomarker

MicroRNA (miRNA) 6762 is a non-coding RNA molecule that plays a crucial role in various biological processes. It is a part of the 220 known miRNA genes and has been identified as a potential drug target and biomarker.

MiRNA 6762 is a small non-coding RNA molecule that contains 194 amino acid residues. It is localized to the cytoplasm of the cells and has been shown to be involved in various cellular processes such as cell growth, apoptosis, and transcriptional regulation.

One of the unique features of miRNA 6762 is its ability to interact with othermiRNAs. This interaction has been shown to play a role in regulating gene expression and can potentially serve as a drug target. The interaction of miRNA 6762 with othermiRNAs has been shown to modulate the levels of target genes, suggesting that it may be a useful biomarker for the drug development process.

In addition to its role in gene expression, miRNA 6762 has also been shown to play a role in cellular signaling pathways. It has been shown to be involved in the regulation of cell adhesion, migration, and the association with the microtubules of the

Protein Name: MicroRNA 6762

The "MIR6762 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR6762 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR6763 | MIR6764 | MIR6765 | MIR6766 | MIR6767 | MIR6768 | MIR6769A | MIR6769B | MIR6770-1 | MIR6770-2 | MIR6770-3 | MIR6771 | MIR6772 | MIR6773 | MIR6774 | MIR6775 | MIR6776 | MIR6777 | MIR6778 | MIR6779 | MIR6780A | MIR6780B | MIR6781 | MIR6782 | MIR6783 | MIR6784 | MIR6785 | MIR6786 | MIR6787 | MIR6788 | MIR6789 | MIR6790 | MIR6791 | MIR6792 | MIR6793 | MIR6794 | MIR6795 | MIR6796 | MIR6797 | MIR6798 | MIR6799 | MIR6800 | MIR6801 | MIR6802 | MIR6803 | MIR6804 | MIR6805 | MIR6806 | MIR6807 | MIR6808 | MIR6809 | MIR6810 | MIR6811 | MIR6812 | MIR6813 | MIR6814 | MIR6815 | MIR6816 | MIR6817 | MIR6818 | MIR6819 | MIR6820 | MIR6821 | MIR6822 | MIR6823 | MIR6824 | MIR6825 | MIR6826 | MIR6827 | MIR6828 | MIR6829 | MIR6830 | MIR6831 | MIR6832 | MIR6833 | MIR6834 | MIR6836 | MIR6837 | MIR6839 | MIR6840 | MIR6841 | MIR6842 | MIR6843 | MIR6844 | MIR6845 | MIR6846 | MIR6847 | MIR6848 | MIR6849 | MIR6850 | MIR6851 | MIR6852 | MIR6853 | MIR6854 | MIR6855 | MIR6856 | MIR6857 | MIR6858 | MIR6859-1 | MIR6859-2